Sept. 17, 2026 (ARLINGTON, VA)– The Bio-Process Systems Alliance (BPSA) recently announced the appointment of three industry leaders to its Scientific Advisory Council (SAC) at the 2026 BPSA International Single-Use Summit, held in July in Boston, MA. The new SAC members are Nelly Montenay of Sartorius, Heidi Sinkovich of Meissner, and Aidan Sexton, PhD, of Johnson & Johnson.

Formed in 2021, the BPSA SAC provides technical direction for the Alliance and supports the development of scientifically grounded resources that advance the adoption and use of single-use technologies. Chaired by BPSA Second Vice Chair, Kirsten Strahlendorf of Sanofi, the SAC oversees BPSA’s technical portfolio, including white papers and other technical projects, and helps guide responses to technical questions from across the bioprocessing community. “We are pleased to welcome Nelly, Heidi, and Aidan to the Scientific Advisory Council,” said Mark Petrich, PhD, of Krystal Biotech & BPSA Chair. “Each brings deep technical expertise and a strong track record of leadership in single-use bioprocessing innovation and manufacturing excellence. Their perspectives will strengthen BPSA’s work in supporting and advancing the safe, scalable, and sustainable use of single-use technologies.”

New Scientific Advisory Council Members

Nelly Montenay is Head of PD Science & Testing at Sartorius. An engineer in polymer sciences, she leads global teams focused on materials science, testing, and scientific advocacy for single-use systems. She has driven initiatives in flexible materials, irradiation strategies, and sustainability, and is also an active contributor to BioPhorum and ECI single-use conferences.

Heidi Sinkovich is Director of Applications Engineering at Meissner Corporation. She leads global engineering teams supporting biopharmaceutical customers and has expertise in sterilization validation and ISO standards. Sinkovich also contributes to ASTM International and ASME BPE standards and has authored industry guidance on particulate control in single-use systems.

Aidan Sexton, PhD, is Senior Principal Scientist, Materials Sciences at Johnson & Johnson Innovative Medicine. With more than 30 years in the industry, he specializes in materials science, validation, and manufacturing support. Sexton has also contributed to multiple BioPhorum best practice guidelines on extractables and leachables and serves in advisory roles, including the ELSIE Board of Directors.

___________________________________________________

About BPSA

The Bio-Process Systems Alliance is an industry-led association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, best practice sharing, development of consensus guides, and networking opportunities among its member companies. For more information, visit www.bpsalliance.org.

ARLINGTON, VA – The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, announced it expanded its Board of Directors to 19 members to lead the organization in 2024/2025 during its recent election.

Kirsten Strahlendorf, M.Eng., P.Eng., PMP, Senior Unit Head, BioProcess Engineering Unit, Sanofi, has been elected Second Vice Chair; Todd Andrews, Director Application and Business Development, Biopharma, CPC, has been re-elected Secretary, and Ravi Narayanan, Global Product Management Leadership-Biopharma & Medical Device, Nordson Medical has been re-elected Treasurer. Also, Chris Wilkins, PhD, Vice President, Strategic Marketing, Filtration Group; Jayanthi Grebin, Business Development Manager Pharmaceuticals NA, Freudenberg Medical; Thomas Vandromme, Business Development Director, Meissner; Monica Cardona, Global Senior Marketing Manager Single Use Systems, Millipore Sigma; Dianne Heiler, Global Head of Packaging Engineering and Sustainability, Repligen Corporation; Brian Chung, Senior Key Account Manager, Specialty Polymers, Solvay and John Puglia, PhD, Senior Director, Global R&D, Thermo Fisher Scientific were elected as Directors-at-Large.

“Congratulations to Kirsten, Todd and Ravi on being elected to the BPSA Executive Board and congratulations to our new and returning BPSA Board members,” said Mark Petrich of Krystal Biotech, BPSA Chair. “I want to thank each of our dedicated volunteer leaders who have chosen to contribute their time and expertise to the BPSA Board. I look forward to working together to advance the mission of BPSA. I would like to express my appreciation to Dan Rosen, Vice President & General Manager, Thermo Fisher Scientific and Scott Patterson, Vice President Pharma & Biotech Technical Support, ILC Dover, whose terms as Directors-at-Large are ending this year.”

BPSA Executive Board Officers:

• Chair: Mark Petrich, PhD, Krystal Biotech
• 1st Vice Chair: Todd Kapp, Entegris, Inc.
• 2nd Vice Chair: Kirsten Strahlendorf, Sanofi
• Secretary: Todd Andrews, CPC
• Treasurer: Ravi Narayanan, Nordson Medical

At-Large Directors (newly elected) through 2025:

• Chris Wilkins, PhD, Filtration Group
• Jayanthi Grebin, Freudenberg Medical
• Thomas Vandromme, Meissner
• Dianne Heiler, Repligen Corporation
• John Puglia, PhD, Thermo Fisher Scientific  

At-Large Directors continuing through 2024/2025:

• Patrick Evrard, Cytiva
• Charlotte Masy, GSK
• Mark Sitcoske, High Purity New England
• Monica Cardona, Millipore Sigma
• Ralph Daumke, PendoTECH
• Danielle Arcuri, Qosina Corporation
• Hernán Parma, RENOLIT Healthcare
• Elisabeth Vachette, Sartorius
• Brian Chung, Solvay

Board members are elected by the general membership and serve staggered two-year terms. The Board determines the governing policies of BPSA, establishes the budget and priorities, and directs the organization’s goals and priority areas of focus.

Please visit https://bpsalliance.org/about/board-of-directors/ for a complete list of BPSA Board of Directors.

The Bio-Process Systems Alliance (BPSA), is an industry-led association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, best practice sharing, development of consensus guides and networking opportunities among its member companies. For more information, visit www.bpsalliance.org, or contact Executive Director Chris Clark at cclark@socma.org.